Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Tamada, Kota ^a,b,c   Tomonaga, Shozo ^a   Hatanaka, Fumiyuki ^a,b,c   Nakai, Nobuhiro ^a,b,c   Takao, Keizo ^d,e,f   Miyakawa, Tsuyoshi ^d,e,f,g   Nakatani, Jin ^a   Takumi, Toru ^a,b,c,g  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e FUJITA HEALTH UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; NORADRENALIN; SEROTONIN; AMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BEHAVIOR CHANGE; BRAIN REGION; CHROMOSOME 15Q; CHROMOSOME DUPLICATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; COPY NUMBER VARIATION; EX VIVO STUDY; EXPLORATORY BEHAVIOR; FOOD DEPRIVATION; GENETIC ASSOCIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT DARK CYCLE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PATHOPHYSIOLOGY; PHENOTYPE; POSTNATAL DEVELOPMENT; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; WILD TYPE; ANIMAL; BRAIN; C57BL MOUSE; CHEMISTRY; CHROMOSOME 15; DISEASE MODEL; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; TRISOMY;

MUS;

AMINES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHROMOSOMES, HUMAN, PAIR 15; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; DOPAMINE; MAZE LEARNING; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; PHENOTYPE; SEROTONIN; SIGNAL TRANSDUCTION; TRISOMY;

EID: 78650730519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015126     Document Type: Article

References (57)

1. Levy SE, Mandell DS, Schultz RT (2009) Autism. Lancet 374: 1627-1638.
2. Chakrabarti S, Fombonne E (2005) Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 162: 1133-1141.
3. Abrahams BS, Geschwind DH (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9: 341-355.
4. Cook EH, Jr., Scherer SW (2008) Copy-number variations associated with neuropsychiatric conditions. Nature 455: 919-923.
5. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, et al. (2006) Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 11(1): 18-28.
6. Cook EH, Jr., Lindgren V, Leventhal BL, Courchesne R, Lincoln A, et al. (1997) Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 60: 928-934.
7. Depienne C, Moreno-De-Luca D, Heron D, Bouteiller D, Gennetier A, et al. (2009) Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry 66: 349-359.
8. Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin Pediatr 8: 348-354.
9. Lam KS, Aman MG, Arnold LE (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27: 254-289.
10. Nakatani Y, Sato-Suzuki I, Tsujino N, Nakasato A, Seki Y, et al. (2008) Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. Eur J Neurosci 27: 2466-2472.
11. Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, et al. (2005) A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30: 582-589.
12. Takumi T (2010) A humanoid mouse model of autism. Brain Dev 32: 753-758.
13. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, et al. (2009) Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137: 1235-1246.
14. Glickman G (2010) Circadian rhythms and sleep in children with autism. Neurosci Biobehav Rev 34: 755-768.
15. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
16. Njung'e K, Handley SL (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38: 63-67.
17. Okado N, Narita M, Narita N (2001) A biogenic amine-synapse mechanism for mental retardation and developmental disabilities. Brain Dev 23(Suppl 1): S11-15.
18. Matsuo N, Takao K, Nakanishi K, Yamasaki N, Tanda K, et al. (2010) Behavioral profiles of three C57BL/6 substrains. Front Behav Neurosci 4: 29.
19. Tsujimura A, Matsuki M, Takao K, Yamanishi K, Miyakawa T, et al. (2008) Mice lacking the kf-1 gene exhibit increased anxiety- but not despair-like behavior. Front Behav Neurosci 2: 4.
20. Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN (2003) Abnormal anxietyrelated behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2: 365-380.
21. Caston J, Chianale C, Delhaye-Bouchaud N, Mariani J (1998) Role of the cerebellum in exploration behavior. Brain Res 808: 232-237.
22. Pierce K, Courchesne E (2001) Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry 49: 655-664.
23. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004) Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881.
24. Ansorge MS, Morelli E, Gingrich JA (2008) Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28: 199-207.
25. Croonenberghs J, Delmeire L, Verkerk R, Lin AH, Meskal A, et al. (2000) Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology 22: 275-283.
26. Umeda T, Takashima N, Nakagawa R, Maekawa M, Ikegami S, Yoshikawa T, Kobayashi K, Okanoya K, Inokuchi K, Osumi N (in press) Evaluation of Pax6 mutant rat as a model for autism. PLoS ONE.
27. Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, et al. (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45: 287-295.
28. Devlin B, Cook EH, Jr., Coon H, Dawson G, Grigorenko EL, et al. (2005) Autism and the serotonin transporter: the long and short of it. Mol Psychiatry 10: 1110-1116.
29. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, et al. (2005) Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77: 265-279.
30. Holmes A (2001) Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci Biobehav Rev 25: 261-273.
31. Hedlund PB (2009) The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) 206: 345-354.
32. Kalueff AV, Olivier JD, Nonkes LJ, Homberg JR (2010) Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 34: 373-386.
33. Holmes A, Murphy DL, Crawley JN (2002) Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161: 160-167.
34. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, et al. (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54: 960-971.
35. Zhao S, Edwards J, Carroll J, Wiedholz L, Millstein RA, et al. (2006) Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience 140: 321-334.
36. Olivier JD, Van Der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, et al. (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152: 573-584.
37. Kalueff AV, Jensen CL, Murphy DL (2007) Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Res 1169: 87-97.
38. Kalueff AV, Fox MA, Gallagher PS, Murphy DL (2007) Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 6: 389-400.
39. Moy SS, Nadler JJ, Young NB, Nonneman RJ, Grossman AW, et al. (2009) Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav 8: 129-142.
40. Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, et al. (2000) Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knockout mice lacking the 5-HT transporter. Eur J Neurosci 12: 2299-2310.
41. Werry TD, Loiacono R, Sexton PM, Christopoulos A (2008) RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther 119: 7-23.
42. Liu R, Jolas T, Aghajanian G (2000) Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res 873: 34-45.
43. Sharp T, Boothman L, Raley J, Queree P (2007) Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 28: 629-636.
44. Sotty F, Folgering JH, Brennum LT, Hogg S, Mork A, et al. (2009) Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects. Neuropharmacology 57: 18-24.
45. Iversen SD, Iversen LL (2007) Dopamine: 50 years in perspective. Trends Neurosci 30: 188-193.
46. Frederick AL, Stanwood GD (2009) Drugs, biogenic amine targets and the developing brain. Dev Neurosci 31: 7-22.
47. Todd RD (1992) Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry 31: 794-807.
48. Stanwood GD, Levitt P (2007) Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. J Neurosci 27: 152-157.
49. Ohtani N, Goto T, Waeber C, Bhide PG (2003) Dopamine modulates cell cycle in the lateral ganglionic eminence. J Neurosci 23: 2840-2850.
50. Zhang L, Bai J, Undie AS, Bergson C, Lidow MS (2005) D1 dopamine receptor regulation of the levels of the cell-cycle-controlling proteins, cyclin D, P27 and Raf-1, in cerebral cortical precursor cells is mediated through cAMPindependent pathways. Cereb Cortex 15: 74-84.
51. Crandall JE, McCarthy DM, Araki KY, Sims JR, Ren JQ, et al. (2007) Dopamine receptor activation modulates GABA neuron migration from the basal forebrain to the cerebral cortex. J Neurosci 27: 3813-3822.
52. Miyakawa T, Yamada M, Duttaroy A, Wess J (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21: 5239-5250.
53. Takao K, Miyakawa T (2006) Light/dark transition test for mice. J Vis Exp. 104 p.
54. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370.
55. Nakajima R, Takao K, Huang SM, Takano J, Iwata N, et al. (2008) Comprehensive behavioral phenotyping of calpastatin-knockout mice. Mol Brain 1: 7.
56. Wang JW, David DJ, Monckton JE, Battaglia F, Hen R (2008) Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 28: 1374-1384.
57. Akashi M, Takumi T (2005) The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 12: 441-448.